Mexico is one of GSK’s growth engines in Latin America. The VP and general manager for Mexico discusses how the country is increasingly playing a…

Oh Pil-Soo, managing director of Lundbeck Korea, talks about the challenges of pricing and reimbursement in the CNS area and remaining committed to…

Dr. Hassan, founder and CEO of Healwell and House of Healin, brings research and entrepreneurship together with the aim of turning Malaysian…

Bayer Malaysia's managing director, Thomas Steffen, discusses the key differences and opportunities offered by the Malaysian market and calls for more…

The managing partner of one of the “big four” consultancies speaks out about market entry strategies for Algeria and how Deloitte itself went…

Long-term strategy is the name of the game for Janssen. Alejandro Smolje, the company’s director of finance for Latin America South, outlines how…

The Mexico country manager of the Swiss biopharmaceutical company discusses the recent restructuring process the subsidiary has been going through,…

Mundipharma Malaysia’s country manager discusses his company's aim to become a reference in Malaysia for pain management, on the back of the…

In the second part of this two-part interview, the chairman of TTY looks back at his experiences in the Taiwanese market, and assess what could have…

Mr. Lebrun discusses the role that BIOQuébec plays in the industry, its aims in representing several sectors and their plans for the coming years.

Country Manager of Norpharma, Denmark, discusses how the company has been able to remain a market competitor while maintaining satisfactory payer…

Chairman of YFY Biotech Management Company discusses the remarkable history of the company, why Taiwan is such an innovative country in the biotech…